openPR Logo
Press release

Human Papillomavirus and Cytomegalovirus Therapeutics Market Growth Analysis 2020

09-28-2017 03:19 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Transparecny Market Research

/ PR Agency: Transparecny Market Research
Human Papillomavirus and Cytomegalovirus Therapeutics Market

Some of the prominent names in The Global Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market.

A report by Transparency Market Research forecasts the global human papillomavirus (HPV) therapeutics market to rise at a CAGR of 7.7% during the period between 2014 and 2020 to become worth US$2.34 bn by 2020 from US$1.40 bn in 2012. According to the report, the global cytomegalovirus (CMV) market will rise at a 1.49 % CAGR from 2014 to 2020 to attain a value of US$922.8 mn by 2020 from US$870.1 mn in 2012.

Fast Developing Healthcare Infrastructure Makes Asia Pacific Attractive Market

Depending upon the types of drugs, the global human papillomavirus (HPV) therapeutics market can be segmented into the following drug classes – anti-neoplastic agents, immunomodulators, sinecatechins, and keratolytic agents. Among them, the immunomodulators leads the market with maximum share. In terms of growth rate, however, the sinecatechins segment will surpass all.

The cytomegalovirus (CMV) therapeutics market, again, can be divided on the basis of antiviral drugs into foscarnet, ganciclovir/valganciclovir (first line drugs), and cidofovir. Of them, ganciclovir and valganciclovir together contribute a lion’s share in the revenue in the overall CMV therapeutics market.

Request to download and view full ToC -

http://www.transparencymarketresearch.com/report-toc/3986

Geographically, the key segments of the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market are North America, South America, Europe, Asia Pacific, and the Rest of the World. At present, South America and Asia Pacific are considered the most lucrative markets on account of the fast developing healthcare infrastructure, increasing affluence of the people, cultural shifts, and a booming tourism industry leading to high instances of STDs.

Request to view Sample Report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3986

Rising Prevalence of HPV Stoking Demand in Market

The alarming rise of human papillomavirus (HPV) in people of both developed and developing nations has been the primary growth driver of the HPV therapeutics market. The lead analyst of the TMR report elaborates, “Over a 100 strains of human papillomavirus (HPV) have been identified so far. Of them, certain types are known to cause warts or papillomas that progress to malignant or benign cancers. HPV infections are common in adolescents and younget adults and is known to affect adolescent females the most. According to Centre for Disease Control (CDC), about 20 million persons were infected in 2012 in the U.S., and an estimated 6.2 million new HPV infections were occurring every year. All these have majorly fuelled the global HPV therapeutics market.”

The cytomegalovirus (CMV) therapeutics market, on the other hand, has received a boost from the launch of brincidofovir in 2016. The launch of letermovir in 2018 will also boost the market.

Serving to deal a blow to the growth in the global human papillomavirus (HPV) market is the relatively dry pipeline of drugs and the availability of different substitute treatments such as laser therapy and cryotherapy.

Human Papillomavirus and Cytomegalovirus Therapeutics Market Report is available @ US$ 5795 http://www.transparencymarketresearch.com/checkout.php?rep_id=3986<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Papillomavirus and Cytomegalovirus Therapeutics Market Growth Analysis 2020 here

News-ID: 746649 • Views: 138

More Releases from Transparecny Market Research

Fly Ash Market Estimated to Reach Us$ 11,371 Mn By 2026
According to a new report published by Transparency Market Research (TMR) titled 'Fly Ash Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026,' the global fly ash market is estimated to reach US$ 11,371.0 Mn by 2026 and is anticipated to expand at a CAGR of 7.1% during the forecast period. Expansion in the global fly ash market is primarily driven by the growth in end-user industries
Carbon Fiber Market to Reap Voluminous Revenues As Automotive Industry Focuses o …
The demand within the global carbon fiber market has been rising on account of advancements in the domain of chemical research and testing, finds Transparency Market Research. The presence of a stellar industry for studying the properties of carbon-based materials has led to the growth of this market. The heavy reliance of the textiles industry on the supply woven carbon filaments has also played a crucial role in accelerating market
Global Enzymes Market to Reach a Valuation Of ~Us$ 12.2 Bn by 2027
Key Highlights: The global enzymes market was valued at approximately ~US$ 6.4 Bn in 2018 and is anticipated to expand at a CAGR of more than 7% from 2019 to 2027 Rise in demand for enzymes for use in the food & beverages processing application is driving the global enzymes market. North America accounted for a major share of the global enzymes market in 2018. Get Research Report Overview @ https://www.transparencymarketresearch.com/enzymes-market.html In terms of demand,
Global Propane Market to Witness 5% CAGR From 2019 to 2027
As per a recent report by Transparency Market Research, the global propane market is expected to experience a consistent growth over the period of 2019 to 2027. The report mentions the facts that due to widespread application of propane in numerous petrochemical industries, the market shall witness 5% CAGR in the mentioned period of 2019 to 2027. Moreover, post analysis of the market, the experts at Transparency Market Research states

All 5 Releases


More Releases for HPV

HPV Vaccines Market Insights by Size, Status and Forecast 2024
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs. More than 40 types of HPV viruses are easily transferred from one person to another by sexual
Cytology and HPV Testing Market - Research Analysis
The nature of the both the markets for cytology testing and HPV or human papillomavirus testing is oligopolistic in nature, states Transparency Market Research (TMR) in a research report. With the presence of only a handful of leading companies in the market, the competition is not that high as they compete among themselves with different or almost similar strategies. These few players are currently enjoying their reign in the global
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017
"The Report Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. Human papillomavirus (HPV) is the most common viral infection
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,
HPV Testing Market 2017- Qiagen, Roche Diagnostics, Hologic
HPV Testing Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. “The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing,
New Research: Global Human Papillomavirus (HPV) Market
MarketResearchReports.Biz presents this most up-to-date research on "Human Papillomavirus (HPV)- Epidemiology Forecast To 2023" Latest Report, Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus (HPV) prevalent or incident cases segmented by age, sex and subpopulations. The